Protagonist Therapeutics Inc. (PGF)
Market Open
27 Feb, 07:01
XBER 
NASDAQ (NMS) Primary XBER €
75. 00
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
0.75 Eps
€ 75
Previous Close Day Range
75 75
Year Range
34.4 81
Want to track PGF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PGF earnings report is expected in 64 days (6 May 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
PGF Earnings Reports FAQ
What is the earnings per share (EPS) for PGF?
The current EPS is 0.75.
What is the company's earnings growth rate?
Protagonist Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-05-06, based on the PGF's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Protagonist Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for PGF at this time, as Protagonist Therapeutics Inc has no recent EPS data to calculate it.
